Please use this identifier to cite or link to this item:
|Title:||Modulatory effects of sesamol in dinitrochlorobenzene-induced inflammatory bowel disorder in albino rats||Authors:||Mathew, Geetha ;Kondamudi, P.K.;Kovelamudi, H.;Nayak, P.G.;Rao, C.M.;Shenoy, R.R.||Issue Date:||2013||Source:||Volume 65, Issue 3, pp. 658 - 665||Journal title:||Pharmacological Reports||Department:||Pharmacy||Abstract:||BACKGROUND: Inflammatory bowel disease (IBD) is a chronic inflammatory condition of gastrointestinal tract of immune, genetic and environmental origin. In the present study, we examined the effect of sesamol (SES), the main anti-oxidative constituent of Sesamum indicum (sesame seed) Linn. in the dinitrochlorobenzene (DNCB)-induced model for IBD in rats. METHODS: The groups were divided into normal control, DNCB control, SES and sulfasalazine (SS). On day 24, the rats were killed, colon removed and the macroscopic, biochemical and histopathological evaluations were performed. RESULTS: The levels of MPO, TBARS and nitrite increased significantly (p < 0.05) in the DNCB group, whereas reduced significantly in the SES, SS treated groups. Serum nitrite levels were found to be insignificant between the different groups. IL-6 and TNF-alpha levels were significantly high in the DNCB group. CONCLUSIONS: We conclude the mucosal protective effect of SES on colon due to its potent antioxidant actions. Further investigation is required in a chronic model of different rodent strain for its role involved in the cytokine pathway.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1788||DOI:||10.1016/s1734-1140(13)71043-0||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/23950588/||ISSN:||1734-1140||Publicaton type:||Journal Article||Keywords:||Drug Therapy|
|Appears in Collections:||Health Service Research|
Show full item record
checked on Dec 8, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.